Table 3.
LC50 of 4H-Pyran-4-One 2,3-Dihydro-3,5-Dihydroxy-6-Methyl.
| Conc. (µg/ml) | % Survival | % Death | ||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 | 2 | 3 | |
| 1000 | 100 | 100 | 100 | 0 | 0 | 0 |
| 500 | 100 | 100 | 100 | 0 | 0 | 0 |
| 100 | 100 | 100 | 100 | 0 | 0 | 0 |
| 10 | 100 | 100 | 100 | 0 | 0 | 0 |
| 1 | 100 | 100 | 100 | 0 | 0 | 0 |
LC 50>1000 µg/ml
LC50 of 4H-Pyran-4-One 2,3-Dihydro-3,5-Dihydroxy-6-Methyl.
| Conc. (µg/ml) | % Survival | % Death | ||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 | 2 | 3 | |
| 1000 | 100 | 100 | 100 | 0 | 0 | 0 |
| 500 | 100 | 100 | 100 | 0 | 0 | 0 |
| 100 | 100 | 100 | 100 | 0 | 0 | 0 |
| 10 | 100 | 100 | 100 | 0 | 0 | 0 |
| 1 | 100 | 100 | 100 | 0 | 0 | 0 |
LC 50>1000 µg/ml